Memory B cells from a subset of treatment naïve relapsing remitting multiple sclerosis patients elicit CD4+ T cell proliferation and IFN-γ production in response to MBP and MOG

Benzer Materyaller

• A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing–remitting multiple sclerosis (TIME MS)
  Yazar:: Remington, Gina M., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease
  Yazar:: Hu, Wei, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis
  Yazar:: Monson, Nancy L., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
  Yazar:: Ireland, Sara J., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
  Yazar:: Matthew Cummings, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-01-01)